These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 93973)

  • 41. Cross-reacting xenoantibodies to the heavy chain of H-2 and HLA-A,B antigens: serologic and immunochemical characterization.
    Callahan GN; Pellegrino MA; Ferrone S
    Scand J Immunol; 1980; 12(4):297-302. PubMed ID: 6162196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin.
    Arce-Gomez B; Jones EA; Barnstable CJ; Solomon E; Bodmer WF
    Tissue Antigens; 1978 Feb; 11(2):96-112. PubMed ID: 77067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Of cows and men: a comparative study of histocompatibility antigens.
    Brodsky FM; Stone WH; Parham P
    Hum Immunol; 1981 Oct; 3(2):143-52. PubMed ID: 7035414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction with a synthetic peptide of antibodies to HLA class I C-terminal intracytoplasmic region.
    Rougon G; Ceard B; Van Rietschoten J; Jordan B; Barbet J
    Mol Immunol; 1984 Jun; 21(6):461-8. PubMed ID: 6379415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primate HLA antibodies are specifically mitogenic for human lymphocytes and act synergistically with beta2m antibodies.
    Ringdén O; Möller E; Sanderson AR
    Scand J Immunol; 1978 Apr; 7(4):337-43. PubMed ID: 77555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
    Belvedere M; Richiardi P; Curtoni ES; Pellegrino MA; Ferrone S
    Immunol Commun; 1979; 8(1):93-106. PubMed ID: 311335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.
    Lampson LA; Fisher CA; Whelan JP
    J Immunol; 1983 May; 130(5):2471-8. PubMed ID: 6187860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of monoclonal anti-alpha 1-microglobulin antibodies: binding strength, binding sites, and inhibition of lymphocyte stimulation.
    Babiker-Mohamed H; Forsberg M; Olsson ML; Winquist O; Nilson BH; Lögdberg L; Akerström B
    Scand J Immunol; 1991 Nov; 34(5):655-66. PubMed ID: 1719614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rapid method for isolation of antigenically active human cell surface antigens associated with beta 2-microglobulin using a monoclonal antibody.
    LeClair K; Van Agthoven A; Terhorst C
    J Immunol Methods; 1981; 41(2):137-44. PubMed ID: 6167640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of HLA antigens on lymphoblastoid and epithelial cell lines and cross-reactivity of HLA-Cw5 and HLA-Cw8.
    O'Toole CM; Lewis CM; Wolf E
    Hum Immunol; 1983 Mar; 6(3):119-31. PubMed ID: 6841162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of molecules bearing HLA determinants in serum and urine.
    Vincent C; Revillard JP
    Transplant Proc; 1979 Jun; 11(2):1301-2. PubMed ID: 89733
    [No Abstract]   [Full Text] [Related]  

  • 52. Cross-reactions of HLA antibodies: VII. Rate of sensitization and serological specificity.
    Kostyu DD; Bernard NF; Amos DB
    Tissue Antigens; 1979 Apr; 13(4):298-306. PubMed ID: 88777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A serological study of the HLA-B17 cross-reactive group.
    Darke C
    Tissue Antigens; 1984 Mar; 23(3):141-50. PubMed ID: 6203186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera.
    Belvedere M; Richiardi P; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Jun; 7(3):215-9. PubMed ID: 6157749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural HLA antibodies.
    Tongio MM; Falkenrodt A; Mitsuishi Y; Urlacher A; Bergerat JP; North ML; Mayer S
    Tissue Antigens; 1985 Nov; 26(5):271-85. PubMed ID: 3879021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-H-2Dd antibodies cross-react with HLA--A11 and Aw31.
    Iványi P; van den Berg-Loonen E; de Greeve P
    Tissue Antigens; 1978 May; 11(5):439-42. PubMed ID: 694908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serological identification of HL-A-linked human "Ia-type" antigens.
    Jones EA; Goodfellow PN; Bodmer JG; Bodmer WF
    Nature; 1975 Aug; 256(5519):651-2. PubMed ID: 1097943
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular characterization of HLA-A, B homologues in owl monkeys and other nonhuman primates.
    Parham P; Ploegh HL
    Immunogenetics; 1980; 11(2):131-43. PubMed ID: 7409864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constancy of cross reactivity patterns during the anti-HL-A response.
    Longo A; Tosi RM; Ferrara G; Azzolina G; Carminati G
    Transplantation; 1975 Dec; 20(6):503-11. PubMed ID: 1209727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations.
    Belvedere M; Richiardi P; Savi M; Curtoni ES; Carbonara AO; Ceppellini R
    Tissue Antigens; 1978 Feb; 11(2):153-62. PubMed ID: 347631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.